INCIDENCE OF NON-SMALL-CELL LUNG CANCER AND BURDEN OF EGFR MUTATIONS: A 10-YEAR GLOBAL FORECAST

被引：0
|
作者：
Ayodele, O. [1 ]
Zhang, N. [1 ]
机构：
[1] Decis Resources Grp, Burlington, MA USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.130
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN48
引用
收藏
页码：A420 / A420
页数：1
相关论文
共 50 条
  • [21] Effect of EGFR mutations on gefitinib in advanced previous treated non-small-cell lung cancer
    Guo, J.
    Zhou, C.
    Deng, Q.
    Ren, S.
    Zhang, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [22] TKI as First Line Treatment in Advanced Non-Small-Cell Lung Cancer with EGFR Mutations
    Guerreiro, Ines
    Silva, Ana Vitor
    Rodrigues, Ana
    Oliveira, Cristina
    Pousa, Ines
    Oliveira, Julio
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1244 - S1245
  • [23] Human Papillomavirus in Non-Small-Cell Lung Cancer: The Impact of EGFR Mutations and the Response to Erlotinib
    Marquez-Medina, Diego
    Gasol-Cudos, Ariadna
    Teresa Taberner-Bonastre, M.
    Samame Perez-Vargas, Juan Carlos
    Salud-Salvia, Antonieta
    Llombart-Cussac, Antonio
    ARCHIVOS DE BRONCONEUMOLOGIA, 2013, 49 (02): : 79 - 81
  • [24] Potential Usage of Afanitib in the Treatment of Non-Small-Cell Lung Cancer with Uncommon EGFR Mutations
    Harada, Taishi
    Yamaba, Yukiko
    Hayata, Hiroki
    Okuda, Takashi
    Kimura, Yoshishige
    Komaki, Toshiyuki
    Kagawa, Keizo
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1241 - S1241
  • [25] Mutation-Specific Antibodies for the Detection of EGFR Mutations in Non-Small-Cell Lung Cancer
    Yu, J.
    Benedettini, E.
    Li, D. Q.
    Gu, T.
    Herebert, H.
    Smith, B.
    Polakiewicz, R.
    Zhou, X. M.
    Loda, M.
    Comb, M.
    MODERN PATHOLOGY, 2009, 22 : 364A - 364A
  • [26] Effectiveness of icotinib against non-small-cell lung cancer with uncommon EGFR mutations.
    Zhou, Shengyu
    Hu, Xingsheng
    Wang, Yan
    Li Junling
    Zhou, Liqiang
    Hao, Xuezhi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [27] Advanced non-small-cell Lung Cancer (NSCLC) Solid Options for EGFR-Mutations
    Roos, Martin
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (10) : 639 - 639
  • [28] EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer
    Fang, Wenfeng
    Huang, Yihua
    Hong, Shaodong
    Zhang, Zhonghan
    Wang, Minghui
    Gan, Jiadi
    Wang, Wenjing
    Guo, Honglin
    Wang, Kai
    Zhang, Li
    BMC CANCER, 2019, 19 (1)
  • [29] Mutation-Specific Antibodies for the Detection of EGFR Mutations in Non-Small-Cell Lung Cancer
    Yu, J.
    Benedettini, E.
    Li, D. Q.
    Gu, T.
    Herebert, H.
    Smith, B.
    Polakiewicz, R.
    Zhou, X. M.
    Loda, M.
    Comb, M.
    LABORATORY INVESTIGATION, 2009, 89 : 364A - 364A
  • [30] Treatment of Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in Clinical Practice
    Yamada, Yutaka
    Tamura, Tomohiro
    Yamamoto, Yusuke
    Ichimura, Hideo
    Hayashihara, Kenji
    Saito, Takefumi
    Yamada, Hideyasu
    Endo, Takeo
    Nakamura, Ryota
    Inage, Yoshihisa
    Satoh, Hiroaki
    Iguchi, Kesato
    Saito, Kazuto
    Inagaki, Masaharu
    Kikuchi, Norihiro
    Kurishima, Koichi
    Ishikawa, Hiroichi
    Sakai, Mitsuaki
    Kamiyama, Koichi
    Shiozawa, Toshihiro
    Hizawa, Nobuyuki
    Sekine, Ikuo
    Sato, Yukio
    Funayama, Yasunori
    Miyazaki, Kunihiko
    Kodama, Takahide
    Hayashi, Shigen
    Nomura, Akihiro
    Nakamura, Hiroyuki
    Furukawa, Kinya
    Yamashita, Takaaki
    Okubo, Hatsumi
    Suzuki, Hisashi
    Kiyoshima, Moriyuki
    Kaburagi, Takayuki
    ANTICANCER RESEARCH, 2020, 40 (10) : 5757 - 5764
12345